DON’T MISS
IamExpat FairIamExpat Job BoardIamExpat Webinars
Newsletters
EXPAT INFO
CAREER
HOUSING
EDUCATION
LIFESTYLE
EXPAT SERVICES
NEWS & ARTICLES
Home
Expat Info
German news & articles
Germany co-signs deal for 300 million doses of coronavirus vaccine
Never miss a thing!Sign up for our weekly newsletters with important news stories, expat events and special offers.
Keep me updated with exclusive offers from partner companies
By signing up, you agree that we may process your information in accordance with our privacy policy

Germany co-signs deal for 300 million doses of coronavirus vaccine

Never miss a thing!Sign up for our weekly newsletters with important news stories, expat events and special offers.
Keep me updated with exclusive offers from partner companies
By signing up, you agree that we may process your information in accordance with our privacy policy
or
follow us for regular updates:



Related Stories

Germany flies in more coronavirus patients from France and ItalyGermany flies in more coronavirus patients from France and Italy
Coronavirus could cost Germany 730 billion eurosCoronavirus could cost Germany 730 billion euros
Lockdown in Germany caused other infectious disease cases to plummetLockdown in Germany caused other infectious disease cases to plummet
Vaccinations delayed in three German states due to shortageVaccinations delayed in three German states due to shortage
Employees German care home accidentally given five doses of COVID-19 vaccineEmployees German care home accidentally given five doses of COVID-19 vaccine
German glassmaker crucial to coronavirus vaccineGerman glassmaker crucial to coronavirus vaccine
Lufthansa to offer passengers coronavirus tests before flightsLufthansa to offer passengers coronavirus tests before flights
German health minister targets April 2021 for coronavirus vaccineGerman health minister targets April 2021 for coronavirus vaccine
For expats of all colours, shapes and sizes

Explore
Expat infoCareerHousingEducationLifestyleExpat servicesNews & articles
About us
IamExpat MediaAdvertisePost a jobContact usImpressumSitemapRSS feeds
More IamExpat
IamExpat Job BoardIamExpat HousingIamExpat FairWebinarsNewsletters
Privacy
Terms of usePrivacy policyCookiesAvoiding scams

Never miss a thing!Sign up for expat events, news & offers, delivered once a week.
Keep me updated with exclusive offers from partner companies
By signing up, you agree that we may process your information in accordance with our privacy policy


© 2025 IamExpat Media B.V.
© 2025 IamExpat Media B.V.
Jun 16, 2020
William Nehra
William studied a masters in Classics at the University of Amsterdam. He is a big fan of Ancient History and football, particularly his beloved Watford FC. Read more

Germany, along with the Netherlands, France and Italy, has collectively signed a contract for 300 million doses of a coronavirus vaccine that is still currently under development.

The vaccination alliance

On Saturday, it was confirmed that Germany, France, Italy and the Netherlands have signed a collective agreement with AstraZeneca, the British-Swedish multinational pharmaceutical company, which will guarantee the supply of a vaccine, as soon as it is discovered.

The terms of the deal have not been disclosed; however it has been confirmed that the vaccinations, which could potentially be as many as 400 million doses, as per the agreement, will be shared across all EU member states that want to participate. If the vaccine is approved, it will be distributed around participating countries according to their population. The population of the EU is approximately 446 million.

The European Commission has shown its inclination towards advance purchase contracts that will allow guaranteed access to a future vaccine, although the Commission has stated it would prefer to negotiate deals on behalf of EU member states itself.

Developing a vaccine

The vaccine, which is being provided by AstraZeneca, was developed by the University of Oxford and is one of just a few vaccines that are currently in the clinical evaluation phase. The university began clinical trials in April and is now increasing their scope to 10.000 participants.

Since the coronavirus pandemic spread across the world, laboratories everywhere have been racing to develop a vaccine. Instead of the typical few years it takes to develop a vaccine, government sources say that the vaccine could be ready by the end of the year, just 12 - 18 months since the development started.

This article first appeared on IamExpat in the Netherlands.

By William Nehra